Elizabeth A. Brem, MD, is an assistant clinical professor in the Division of Hematology/Oncology, School of Medicine at the University of California, Irvine.
Drawing Comparisons for Relevant Therapies in Patients With DLBCL
Elizabeth A. Brem, MD, discusses treatment options for patients with diffuse large B-cell lymphoma.
Hematologists Should Consider What Comes Next for Patients With DLBCL
Elizabeth A. Brem, MD, discusses the familiarity of treatments among oncologists for patients with diffuse large B-cell lymphoma in a Case-Based Roundtable event.
Community Oncologists Show Comfort With Bispecifics in B-Cell Lymphoma
Elizabeth A. Brem, MD, discusses the shift she has seen in the community setting when it comes to using bispecific antibody therapy for patients with B-cell lymphoma.